QCLS

Q/C Technologies, Inc. Common Stock

QCLSNASDAQ

Q/C Technologies, Inc. Common Stock is a in vitro & in vivo diagnostic substances company trading on NASDAQ, led by CEO Joshua N. Silverman, with a market cap of $14.7M.

CEOJoshua N. Silverman
Market Cap$14.7M
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

Next Earnings

Upcoming earnings announcement for Q/C Technologies, Inc. Common Stock

Date
Friday, April 10, 2026 (in 2 months)
Timing
After Market Close (5:00 PM New York)
Fiscal Period
Q4 2025

Earnings History

Past 1 earnings report for Q/C Technologies, Inc. Common Stock

DatePeriodEPSEPS SurpriseRevenueRev. SurpriseFiling
Nov 19, 2025Q3 2025
-$2.50
-
SEC10-Q

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.